News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
77 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17572)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (132)
2 (127)
3 (87)
6 (127)
7 (145)
8 (118)
9 (121)
10 (92)
13 (111)
14 (159)
15 (129)
16 (143)
17 (127)
20 (77)
21 (182)
22 (154)
23 (156)
24 (100)
27 (137)
28 (179)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
6
7
8
9
10
13
14
15
16
17
20
21
22
23
24
27
28
Drug Development
Phase II Study Supports Potential For Genentech’s Tecentriq (Atezolizumab) Plus Avastin (Bevacizumab) For People With Locally Advanced Or Metastatic Renal Cell Carcinoma
February 20, 2017
·
1 min read
Appili Awarded $2.8M From ACOA To Fund Clinical Trials
February 20, 2017
·
2 min read
Drug Development
Xencor Release: Igg4-Related Disease Biomarker Development Update Presented From An Ongoing, Open-Label, Phase II Study Of Xmab5871 In Igg4-RD At The 3rd International Symposium On Igg4-Related Diseases & Fibrosis
February 20, 2017
·
4 min read
Drug Development
Hutchison China MediTech (Chi-Med) Initiates A Phase II Study Of Savolitinib In Pulmonary Sarcomatoid Carcinoma
February 20, 2017
·
4 min read
Business
Courtagen Launches Avantra Genetics to Provide Personalized Genetic Info for Functional Medicine
February 20, 2017
·
2 min read
Deals
Orexo Completes Bond Buyback Program
February 20, 2017
·
1 min read
Medicomp Inc. Introduces Quippe Clinical Lens To Help Physicians At The Point-Of-Care
February 20, 2017
·
4 min read
Genetown
Linguamatics Ltd To Provide Varian Medical Systems With NLP Technology For Oncology Care Management Platform
February 20, 2017
·
3 min read
Seward To Showcase New Cost-Saving Stomacher 400 EVO Laboratory Blender At Pittcon 2017
February 20, 2017
·
3 min read
Horizon Discovery Ltd. Launches Multiplex I cfDNA Reference Standard Set In Synthetic Plasma
February 20, 2017
·
2 min read
Previous
5 of 8
Next